Studien

Victorion Challenge:  A randomized, multicenter, open-label trial comparing the effectiveness of Inclisiran to bempedoic acid on LDL cholesterol (LDL-C) lowering in participants with atherosclerotic cardiovascular disease (VICTORION-CHALLENGE)

CABA- HFPEF: Catheter-Based Ablation of atrial fibrillation compared to conventional treatment in patients with Heart Failure with Preserved Ejection Fraction.
NCT 05508256

The COLECTRO-AF Trial: Randomised, double-blind, placebo-controlled, multicentre trial in all patients with AF undergoing ECV with successful sinus rhythm restoration for at least 30 minutes
NCT05890664

EASThigh-AFNET 11: Early Atrial Fibrillation Ablation For Stroke Prevention In Patients With high Comorbidity Burden

Global ParadiseTM System Register: The GPS Registry is a multi-centre, single-arm, non-interventional (observational) registry. In addition to collecting data from patients treated as per standard clinical practice, the Registry will also regularly collect telemetric Home Blood Pressure (HBP) measurements and Patient Reported Outcome (PRO) data via a standardized quality of life questionnaire. The objective of the GPS Registry is to document the long-term safety and effectiveness of the commercially available Paradise Ultrasound Renal Denervation System when used per its labelling in patients deemed to be candidates for RDN as per physician's assessment.

THRIVE_Sonivie: Study Title: A Pivotal, Prospective, Multicenter, 2:1 Randomized, Double Blind, Controlled, Study Comparing the THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System vs. Sham for the Adjunctive Treatment of Hypertension (The THRIVE Study).
ClinicalTrials.gov #: NCT06559891

TRAMmoniTTR_Centogene TRAM2 analysis, 02-2018: Genetic screening of an at-risk population for Hereditary TransthyRetin-related AMyloidosis and longitudinal monitoring of TTR positive subjects